trial · primary record
Atezolizumab
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 430 |
| Primary completion | 2027-12-15 |
| Primary endpoint | Progression free survival (PFS) (Phase II) |
| Registry ID | NCT05063552 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:30.451Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05063552
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Atezolizumab · approval
- Atezolizumab · compound